2

Size: px
Start display at page:

Download "2"

Transcription

1 1

2 2

3 3

4 4

5 5

6 6

7 7

8 8

9 9

10 10

11 11

12 Summary of in vitro analysis 12

13 13

14 Summary of in vivo results SHIV primer binding site 1 in vivo gp41 14

15 15

IF_SUPRECUR_N29

IF_SUPRECUR_N29 ! @ # $ % ^ & * ( ) _ + )# ! a s d a s d f g h a s d @ a s d a s # a s d f g h j $ a s d f g h a s d % a s a a s a s a s d f g ^ a s a s a s & a s d f a s d f g h a s d f g a s d f g a s d a s d * s

More information

KRAS KRAS

KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS : KRAS in vitro KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS

More information

Helicobacter pylori in vitro in vivo in vitro in vivo in vitro in vivo in situ In situ in situ in situ AluI i i e eiii i K K rrr i i i ii i ii e i iie i i i i eae eae tir cest eae tir

More information

計画の立て方1巻とびら.indd

計画の立て方1巻とびら.indd CONTENTS Lesson 1 Lesson 2 Lesson 3 Lesson 4 Lesson 5 Lesson 6 Lesson 7 Lesson 8 Summary 8 10 12 14 16 18 20 22 24 Lesson 1 Lesson 2 Lesson 3 Lesson 4 Lesson 5 Lesson 6 Summary 26 28 30 32 34 36 38 4 Lesson

More information

論文9.indd

論文9.indd Recent topics in surround sound audio Masaki Sawaguchi Summary This paper will describe the recent trends in surround sound system based on the results of various investigations on this topic. According

More information

nsg02-13/ky045059301600033210

nsg02-13/ky045059301600033210 φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W

More information

2007050781......_.L.O...z.W

2007050781......_.L.O...z.W a s d f g a s d f g h j k l 0 in vitro in vivo in vitro in vivo in vivo in vivo in vitro Metabolism Metabolism Endocr Endocr Endocrinol Ann NYA cad Sci J clin Endocr Metab

More information

<834A8358835E837D83438359837D836A83858341838B2D30312E6169>

<834A8358835E837D83438359837D836A83858341838B2D30312E6169> 01 1 2 3 4 02 03 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 04 1 2 1 2 3 3 05 06 01 02 03 04 01 02 03 04 05 SITE Web Site Welcome to my home page. SITE Web Site Welcome to my home page.

More information

RASSF1 RASSF1 EGFR EGFR Nalú Navarro Alvarez In vitro In vivo Aeromonas sobria Vitis coignetiae Meg1/Grb10 CHARLES WILSON MESSO Drosophila melanogaster Arabidopsis thaliana PEECHAPACK SOMYOONSAP peg peg

More information

untitled

untitled 20 21 3 20(2008) 4 1 27(2015) 3 31 1 3 1 3 1 3 5 2 4 20(2008) FD AO 1 3 GP 3 12(2000) 21(2009) CUC 15(2003) ISO14001 GP GP 3 19(2007) 1 2 80 2 3 5 2 4 21(2009) 20(2008)FD 3 3 14(2002) 3 4 20(2008) LIVE

More information

VOL.35 S-2 CHEMOTHERAPY Table 1 Sex and age distribution Table 2 Applications of treatment with carumonam Table 3 Concentration of carumonam in human

VOL.35 S-2 CHEMOTHERAPY Table 1 Sex and age distribution Table 2 Applications of treatment with carumonam Table 3 Concentration of carumonam in human CHEMOTHERAPY Fig. 1 Chemical structure of carumonam Disodium(+)-(Z)-CCE1-(2-amino-4-thiazoly1)-2-[[(2S, -(carbamoyloxymethyl)-4-oxo-1-sulfonato-3-azetidinyll -2-oxoethylidene] amino] oxy] acetate 3S)-2

More information

DocuCentre-III C3300 / C2200

DocuCentre-III C3300 / C2200 C3300 / C2200 2 3 50 45 35 35 35 35 G4 G3 Management Ecology Scan Fax Print Copy C3300 / C2200 Product Summary 4 5 SCAN 6 7 COPY 8 9 PRINT 10 FAX 11 SECURITY 12 12 13 13 MANAGEMENT IC Card Gate IC Card

More information

nsg04-28/ky208684356100043077

nsg04-28/ky208684356100043077 δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!

More information

11 11 13 13 13 13 14 14 15 16 16 17 17 17 18 18 21 21 23 24 25 25 26 1 26 27 29 34 34 34 35 35 37 39 41 42 42 43 44 44 44 45 46 46 47 47 48 48 49 50 50 50 51 52 52 53 53 54 55 55 55 55 2 56 57 57 58 59

More information

Newman

Newman 32 2001 pp.237 297 ISSN 0287 6817 Toshihiko AMEMIYA Kenichi NAITOH Abstract 237 students were asked to evaluate and propose a reform plan of their university campus as a course report of environmental

More information

日本化学療法学会雑誌第56巻第3号

日本化学療法学会雑誌第56巻第3号 β Key words Candida albicans albicans Candida C. albicans Candida glabrata Candida krusei albicans Candida C. glabrata C. albicans albicans Candida β in vitro in vivo C. glabrata C. krusei I β γ µ Candida

More information

µ µ µ µ

µ µ µ µ Title 東 京 歯 科 大 学 研 究 年 報 : 平 成 15 年 度 Journal 東 京 歯 科 大 学 研 究 年 報, (): - URL http://hdl.handle.net/10130/388 Right Posted at the Institutional Resources for Unique Colle Available from http://ir.tdc.ac.jp/

More information

http://www.who.int/ipcs/publications/ehc/en/index.html EHC 1 2 3 4 / EHC http://www.nihs.go.jp/dcbi/publist/ehchsg/ 1-8) WHO/IPCS CICAD (Concise Inter

http://www.who.int/ipcs/publications/ehc/en/index.html EHC 1 2 3 4 / EHC http://www.nihs.go.jp/dcbi/publist/ehchsg/ 1-8) WHO/IPCS CICAD (Concise Inter 3 [ ] Priority IARC JMPR 2004 10 Priority 1 Priority 1 Priority 2 Priority 3 Priority 1 1-1) CERI) http://www.cerij.or.jp/ceri_jp/koukai/sheet/sheet_indx4.htm http://www.safe.nite.go.jp/data/sougou/pk_list.html?table_name=hyoka&rank=sh

More information

untitled

untitled 1 80 28 100 11 7-1- 2.49 1.89 1.29 0.69 1 1 10 50-2- 65 2 75 2 85 2 95 2 Aw -3- ( ) ( ) 5 5 0 10 ( ) ( ) ( ) -4- -5- 100 1 4 100 31 HACCP Hazard Analysis Critical Control Points 62 65 30-6- -7- -8- 100

More information

[ ]...1 [ ] Inverse PCR...2 [ ]...3 [ ]...4 Plasmid PCR Primer...4 PCR...5 PCR 2nd-site mutation...5 Plasmid...6 [ ]...8 Inverse PCR Dpn I

[ ]...1 [ ] Inverse PCR...2 [ ]...3 [ ]...4 Plasmid PCR Primer...4 PCR...5 PCR 2nd-site mutation...5 Plasmid...6 [ ]...8 Inverse PCR Dpn I 06-12 KOD - Plus- Mutagenesis Kit (Code No. SMK-101) TOYOBO CO., LTD. Life Science Department OSAKA JAPAN 0 [ ]...1 [ ] Inverse PCR...2 [ ]...3 [ ]...4 Plasmid.....4 PCR Primer...4 PCR...5 PCR 2nd-site

More information

Ⅱ 方法と対象 1. 所得段階別保険料に関する情報の収集 ~3 1, 分析手法

Ⅱ 方法と対象 1. 所得段階別保険料に関する情報の収集 ~3 1, 分析手法 67 論文 要旨 : 1507 キーワード : Ⅰ 緒言 65 2014 89 5 2 3 5 6 2 5 6 3 4 3 4 2006 2015 9 9 68 2018. 3 2015 Ⅱ 方法と対象 1. 所得段階別保険料に関する情報の収集 6 2015 7 2016 2 ~3 1,507 2. 分析手法 69 3 3 3 A B C 3 A 4 1 1 2 2 2014 2014 2014 5

More information

SAS Enterprise Guideによるデータ解析入門

SAS Enterprise Guideによるデータ解析入門 ........ 1 / 70.... SAS Enterprise Guide Kengo NAGASHIMA Laboratory of Biostatistics, Department of Parmaceutical Technochemistry, Josai University 2010 11 16 ........ 2 / 70 (SAS / SAS Enterprise Guide

More information

PowerPoint Presentation

PowerPoint Presentation CLC Microbial Genomics Module 株式会社キアゲングローバルインフォマティクスソリューションズ & サポートアプライドアドバンストゲノミクス宮本真理 Ph.D. Filgen WebEx seminar, 2015/07/16 (2015/07/30) 1 Agenda メタゲノミクス解析 製品概要 機能紹介 デモ Filgen WebEx seminar, 2015/07/16

More information

本文(14Q2段組)2/YA8021C

本文(14Q2段組)2/YA8021C ! "!" ! " ! "! "!" !"! "!"! "!"! "! "!"!"! "!"!"!"! "! "!"!"! "! "! " !"! "! "!"!"!"! "! " ! "! " !"! "! " !" ! "!"! "!"! "!"!"!" !"!"!"!"!"!"! "!"!" !" ! " sd1 !"! " !"! " !"! " ! " ! " !

More information

7 / 70 8 / 70 SAS Enterprise Guide, Windows SAS, SAS,,,, SAS SAS Enterprise Guide SAS: SAS Enterprise Guide:, SAS SAS Enterprise Guide... 5 / 70 6 / 7

7 / 70 8 / 70 SAS Enterprise Guide, Windows SAS, SAS,,,, SAS SAS Enterprise Guide SAS: SAS Enterprise Guide:, SAS SAS Enterprise Guide... 5 / 70 6 / 7 3 / 70 4 / 70 SAS Enterprise Guide (SAS / SAS Enterprise Guide ) Kengo NAGASHIMA Laboratory of Biostatistics, Department of Parmaceutical Technochemistry, Josai University 2010 11 16 1 / 70 2 / 70 SAS

More information

ir資料4 2.ai

ir資料4 2.ai Outline of business Outline of business Outline of business Outline of business Achievement transition Achievement transition Achievement transition Achievement transition Achievement transition Profit

More information